Iovance Biotherapeutics, Inc. Common Stock
Veridion Score
Composite trend over time
Why is IOVA moving today?
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for IOVA.
IOVA insider activity
Iovance Biotherapeutics, Inc. Common Stock
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for IOVA.
IOVA contract awards, year to date.
Public federal awards linked to this ticker.
IOVA lobbying filings, year to date.
Registered lobbying filings matched to Iovance Biotherapeutics, Inc. Common Stock.